"Renal Elimination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The discharge of substances from the blood supply via the URINARY TRACT.
| Descriptor ID |
D065667
|
| MeSH Number(s) |
G03.787.410 G07.690.725.609 G08.852.761
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Renal Elimination".
Below are MeSH descriptors whose meaning is more specific than "Renal Elimination".
This graph shows the total number of publications written about "Renal Elimination" by people in this website by year, and whether "Renal Elimination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 4 | 6 | 10 |
| 2018 | 2 | 4 | 6 |
| 2019 | 1 | 1 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Renal Elimination" by people in Profiles.
-
Severe Inflammation, Acute Kidney Injury, and Drug-Drug Interaction: Triple Penalty for Prolonged Elimination of Apixaban in Patients With Coronavirus Disease 2019: A Grand Round. Ther Drug Monit. 2021 08 01; 43(4):455-458.
-
Favipiravir use in children with COVID-19 and acute kidney injury: is it safe? Pediatr Nephrol. 2021 11; 36(11):3771-3776.
-
Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine. Am J Kidney Dis. 2021 07; 78(1):142-145.
-
The renin-angiotensin-aldosterone system inhibitors in COVID-19: from acidosis to ventilation and immunity. Swiss Med Wkly. 2020 11 30; 150:w20444.
-
Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function. Adv Chronic Kidney Dis. 2020 09; 27(5):434-441.
-
Low molecular weight heparins in COVID-19 patients: beware of augmented renal clearance! Crit Care. 2020 06 10; 24(1):325.
-
COVID-19 therapeutic options for patients with kidney disease. Kidney Int. 2020 06; 97(6):1297-1298.
-
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 06; 95(6):1304-1317.
-
Prediction of the Renal Elimination of Drugs With Cystatin C vs Creatinine: A Systematic Review. Mayo Clin Proc. 2019 03; 94(3):500-514.
-
PEGylated BF2-Azadipyrromethene (NIR-AZA) fluorophores, for intraoperative imaging. Eur J Med Chem. 2019 Jan 01; 161:343-353.